Biblio
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry. Cytometry B Clin Cytom. 2022.
. Early assessment of clofarabine effectiveness applying measurable residual disease, including AML stem cells. Blood. 2020.
. Genomic landscape of retinoblastoma in Rb(-/-) p130(-/-) mice resembles human retinoblastoma. Genes Chromosomes Cancer. 2016.
. Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel. Am J Hematol. 2023.